Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure Via SIRT3 Stimulation in Pulmonary Arterial Hypertension
Overview
Endocrinology
Authors
Affiliations
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vessel remodeling; however, its severity and impact on survival depend on right ventricular (RV) failure. Resveratrol (RES), a polyphenol found in red wine, exhibits cardioprotective effects on RV dysfunction in PAH. However, most literature has focused on RES protective effect on lung vasculature; recent finding indicates that RES has a cardioprotective effect independent of pulmonary arterial pressure on RV dysfunction, although the underlying mechanism in RV has not been determined. Therefore, this study is aimed at evaluating sirtuin-3 (SIRT3) modulation by RES in RV using a monocrotaline- (MC-) induced PAH rat model. Myocyte function was evaluated by confocal microscopy as cell contractility, calcium signaling, and mitochondrial membrane potential (ΔΨ); cell energetics was assessed by high-resolution respirometry, and western blot and immunoprecipitation evaluated posttranslational modifications. PAH significantly affects mitochondrial function in RV; PAH is prone to mitochondrial permeability transition pore (mPTP) opening, thus decreasing the mitochondrial membrane potential. The compromised cellular energetics affects cardiomyocyte function by decreasing sarco-endoplasmic reticulum Ca-ATPase (SERCA) activity and delaying myofilament unbinding, disrupting cell relaxation. RES partially protects mitochondrial integrity by deacetylating cyclophilin-D, a critical component of the mPTP, increasing SIRT3 expression and activity and preventing mPTP opening. The preserved energetic capability rescues cell relaxation by maintaining SERCA activity. Avoiding Ca transient and cell contractility mismatch by preserving mitochondrial function describes, for the first time, impairment in excitation-contraction-energetics coupling in RV failure. These results highlight the importance of mitochondrial energetics and mPTP in PAH.
Zhang K, Jiang L, Xue L, Wang Y, Sun Y, Fan M Nutrients. 2024; 16(7).
PMID: 38613012 PMC: 11013747. DOI: 10.3390/nu16070978.
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
Li M, Plecita-Hlavata L, Dobrinskikh E, McKeon B, Gandjeva A, Riddle S Am J Respir Cell Mol Biol. 2023; 69(5):570-583.
PMID: 37343939 PMC: 10633840. DOI: 10.1165/rcmb.2022-0360OC.
Zeng Z, Wang X, Cui L, Wang H, Guo J, Chen Y Curr Issues Mol Biol. 2023; 45(3):2351-2371.
PMID: 36975522 PMC: 10047369. DOI: 10.3390/cimb45030152.
Sun J, Pu C, Yang E, Zhang H, Feng Y, Luo P Cell Mol Neurobiol. 2023; 43(6):2871-2882.
PMID: 36786945 PMC: 11410121. DOI: 10.1007/s10571-023-01325-9.
A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation.
Tyagi A, Pugazhenthi S Int J Mol Sci. 2023; 24(2).
PMID: 36675125 PMC: 9866791. DOI: 10.3390/ijms24021615.